Qiagen's $130M Purchase of DxS a 13X Profit for Investors Sep. 30, 2009 By Nuala Moran LONDON - There was a record return for all the investors in companion diagnostics pioneer DxS Ltd., when the company was acquired last week by Qiagen NV for a total of up to $130 million. (BioWorld International)Read More
RSS